Abstract:Abstract Breast cancer represents 25% of all cancers diagnosed in women globally with almost 1.7 million new cases annually. The average survival rate for patients with early stage breast cancer has increased, however the survival rate for those with metastatic breast cancer has not improved. Metastasis is the number one cause of death in breast cancer patients; it remains a scientific enigma, with no available early detection screen or targeted therapies available to patients. Therefore, understanding how and why cancer cells migrate is of significant biological and clinical interest. Accumulating evidence suggests the metastatic potential of breast cancer is influenced by the composition of the extracellular matrix (ECM). The ECM is composed of fibrous proteins and other non-cellular biomolecules and has a well-documented role in influencing tumour structure and behaviour. We are examining genes that code for several categories of proteins involved in regulating the composition of the ECM. These genes code for proteins that are involved in signal transduction from the cell membrane or for proteins that are secreted into the ECM. We are also examining genes that code for fibrous proteins, glycoproteins, transmembrane proteins, growth factors and proteases. To refine our panel, we used STRING [1], an online database, to examine the relationships between the proteins coded by our genes based on the experimental determination of protein co-expression and protein homology. Using qRT-PCR, we are examining the expression of our refined gene set in three different cell lines, (representing the major sub-categories of breast cancer) which have been cultured on collagen, fibronectin, laminin and stimulated by various growth factors. We extended our study to examine the expression pattern in cells that were maintained in 3-Dimensional culture over a period of 10 days in an attempt to mimic more closely the physiological process. We have determined that there is significant differential gene expression of integrins and growth factor binding proteins as we change the composition of the cells culture environment. This work is helping us to refine a signature set by identifying genes whose expression is dysregulated in response to changes in the stromal environment. We are moving now to determining whether dysregulation of the expression of our gene panel correlates with disease progression by examining matched normal and diseased patient tissue. This could provide the opportunity to generate a novel gene signature that may be used as a prognostic tool to predict invasive cancers. It may also provide information on the design of novel treatment therapies for patients with metastatic cancers. 1. Szklarczyk, D., et al., The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res, 2017. 45(D1): p. D362-d368. Citation Format: Joanne Nolan, Maeve Kiely, Colum P. Dunne, Aoife J. Lowery, Patrick A. Kiely. Examining how the extracellular environment alters gene expression in breast cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 189.

Potential Misinterpretation of Data on Differential Gene Expression in Normal and Malignant Cells in Vitro

Analysis of Serum Exosomal Micrornas and Clinicopathologic Features of Patients with Pancreatic Adenocarcinoma

Differences in gene expression in prostate cancer, normal appearing prostate tissue adjacent to cancer and prostate tissue from cancer free organ donors

Lipid-Restricted Culture Media Reveal Unexpected Cancer Cell Sensitivities

The Expression of GPRC5A in Cultured Normal and Malignant Cells is Modulated by Endogenous Retinoids in Serum

Towards characterization of cell culture conditions for reliable proteomic analysis: in vitro studies on A549, differentiated THP-1, and NR8383 cell lines

Editing Genomic DNA in Cancer Cells with High Genetic Variance: Benefit or Risk?

Genes Dysregulated To Different Extent Or Oppositely In Estrogen Receptor-Positive And Estrogen Receptor-Negative Breast Cancers

Understanding natural isotopic variations in cultured cancer cells

Quantitation of a “Malignancy Index” of the Relationship between Glioblastoma Microtumor Mass and Invasive Potential Using A Chicken Egg Albumen Matrix to Define Biomechanical Density Parameters that Promote Malignant Progression

Characterization of transcriptome diversity and in vitro behavior of primary human high-risk breast cells

Applying Proteomic Methodologies to Analyze the Effect of Methionine Restriction on Proliferation of Human Gastric Cancer SGC7901 Cells.

Abstract 5567: Breast cancer cell alteration of immune cell transcriptome through indirect communication

Revealing Extensive Up - Regulation of Gene Expression in Pancreatic Cancer Based on Microarray Data

The Influence Of The Global Gene Expression Shift On Downstream Analyses

Abstract 189: Examining how the extracellular environment alters gene expression in breast cancer

Comparative Analysis of Gene Expression Profiles in Ovarian Clear Cell Carcinoma and High-Grade Serous Ovarian Cancer

Proteomic Study of Esophageal Squamous Cell Carcinoma

Extracellular Matrix–receptor Interaction Signaling Genes Associated with Inferior Breast Cancer Survival

Prediction of multiple drug resistance phenotype in cancer cell lines using gene expression profiles and phylogenetic trees

Genetic Profiles Affect the Biological Effects of Serine on Gastric Cancer Cells